Literature DB >> 29127573

Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.

Shogo Matsuda1, Shuzo Yoshida2, Youhei Fujiki2, Hidetoshi Satomi2, Tohru Takeuchi2, Yoshinobu Hirose2, Shigeki Makino2, Shigeki Arawaka2.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by necrotizing vasculitis of small-sized vessels with extravascular granulomas and eosinophilic infiltration. The case of a 48-year-old Japanese woman with EGPA, who presented concurrently with subarachnoid hemorrhage (SAH) and coronary vasculitis, is reported. She initially presented with bronchial asthma, and then 8 months later she developed various symptoms caused by systemic eosinophilic vasculitis and was admitted to our hospital. Three days after admission, she started oral corticosteroid therapy, and her 2009 Five-Factor Score (FFS) was 0. However, she developed an SAH, followed by coronary vasculitis 1 day later. With extensive treatment with a combination of betamethasone, cyclophosphamide, intravenous immunoglobulin, and rituximab, her systemic vasculitis improved dramatically. This seems to be the first case of EGPA with SAH and coronary vasculitis. In previous reports of EGPA with SAH, 4 of 11 cases developed SAH as an exacerbation of systemic vasculitis during remission induction therapy. The present patient also had SAH during remission induction therapy. However, the period between bronchial asthma and SAH was only 8 months. This is the shortest among case reports of EGPA with SAH. In addition, the present patient rapidly developed coronary vasculitis. These findings suggest that EGPA causes SAH and coronary vasculitis as early complications of systemic vasculitis. In EGPA, it is necessary to pay careful attention to rapid changes of disease activity, even when the FFS indicates a good prognosis.

Entities:  

Keywords:  Coronary vasculitis; Eosinophilic granulomatosis with polyangiitis; Five-Factor Score; Subarachnoid hemorrhage; Vasculitic stage

Mesh:

Substances:

Year:  2017        PMID: 29127573     DOI: 10.1007/s00296-017-3875-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Cardiac involvement in small and medium-sized vessel vasculitides.

Authors:  C Pagnoux; L Guillevin
Journal:  Lupus       Date:  2005       Impact factor: 2.911

2.  Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.

Authors:  Una-Marie Sheerin; Julio Barreto; Martin M Brown; Stefan Brew; Nicholas A Losseff
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

3.  Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients.

Authors:  Pascal Cohen; Christian Pagnoux; Alfred Mahr; Jean-Pierre Arène; Luc Mouthon; Véronique Le Guern; Marie-Hélène André; Martine Gayraud; David Jayne; Daniel Blöckmans; Jean-François Cordier; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2007-05-15

4.  Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Authors:  Vincent Cottin; Elisabeth Bel; Paolo Bottero; Klaus Dalhoff; Marc Humbert; Romain Lazor; Renato A Sinico; Pasupathy Sivasothy; Michael E Wechsler; Matthieu Groh; Sylvain Marchand-Adam; Chahéra Khouatra; Benoit Wallaert; Camille Taillé; Philippe Delaval; Jacques Cadranel; Philippe Bonniaud; Grégoire Prévot; Sandrine Hirschi; Anne Gondouin; Bertrand Dunogué; Gérard Chatté; Amandine Briault; David Jayne; Loïc Guillevin; Jean-François Cordier
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

5.  Neurological complications of systemic vasculitis. A report of 2 cases.

Authors:  A Maloon; V U Fritz; C L Kaplan
Journal:  S Afr Med J       Date:  1985-10-12

Review 6.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

7.  Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

Authors:  Naomi Tsurikisawa; Masami Taniguchi; Hiroshi Saito; Hideo Himeno; Akihiko Ishibashi; Shunsuke Suzuki; Kazuo Akiyama
Journal:  Ann Allergy Asthma Immunol       Date:  2004-01       Impact factor: 6.347

8.  Churg-Strauss syndrome presenting as spontaneous subarachnoid haemorrhage.

Authors:  José Maria Calvo-Romero; M del Carmen Bonilla-Gracia; P Bureo-Dacal
Journal:  Clin Rheumatol       Date:  2002-06       Impact factor: 2.980

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report.

Authors:  Giuseppe Taormina; Giuseppe Andolina; Maria Aurelia Banco; Edy Julia Costanza-Gaglio; Alice Bonura; Silvio Buscemi
Journal:  J Med Case Rep       Date:  2014-06-13
View more
  2 in total

1.  Cardiac involvement in eosinophilic granulomatosis with polyangiitis.

Authors:  Tatjana Zekić
Journal:  Rheumatol Int       Date:  2017-11-24       Impact factor: 2.631

Review 2.  Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.

Authors:  Jingjing Xie; Ertao Jia; Suli Wang; Ye Yu; Zhiling Li; Jianyong Zhang; Jia Li
Journal:  Clin Rheumatol       Date:  2022-06-11       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.